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As the life expectancy of patients with cystic fibrosis increases, unusual complications including amyloidosis are increasingly recognised.
We report three cases of amyloidosis including a unique case presenting with a hemorrhagic and thrombotic diatheisis. This complication of
amyloidosis has never been reported in cystic fibrosis.
D 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Amyloidosis; ThrombosisInflammation-associated systemic amyloidosis (AA) is a
well-established complication of chronic infections, inflam-
matory and neoplastic diseases. AA occurs when there is an
imbalance between the production and degradation of serum
amyloid A protein (SAA), leading to its accumulation and
deposition in various organs. In adults AA is associated with
inflammatory states such as rheumatoid arthritis, tuberculo-
sis, osteomyelitis and bronchiectasis.
The first case of amyloidosis complicating cystic fibrosis
(CF) was reported in 1967. Amyloidosis in association with
CF mostly presents with proteinuria, thyromegaly and hepa-
tosplenomegaly. We present three cases of amyloidosis in-
cluding an unusual presentation, not formally described in
CF.1. Case 1
A 20-year-old, CF female (genotype DF508/G551D) was
admitted with an infectious exacerbation and pyrexia. Her1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2005.09.010
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E-mail address: annemariemclaughlin@eircom.net (A.M.McLaughlin).FEV1 was 0.8 l, she had been awaiting lung transplant for 2
months. CT chest demonstrated a 43 cm mass in the
anterior mediastinum. Needle aspiration revealed purulent
material suggestive of an abscess, culture was sterile. Despite
antimicrobial therapy she remained pyrexial. Echocardio-
gram and vascular ultrasound identified coexisting thrombi in
the right atrium, right internal jugular, and popliteal veins.
Intravenous (IV) heparin was initiated. Four days later bloody
diarrhoea developed. Colonoscopy and biopsy, revealed
normal colonic mucosa with some ulceration leading to a
diagnosis of none specific colitis. Despite bloody diarrhoea
low dose subcutaneous heparin (1 mg/kg twice daily) was
maintained in view of the cardiac thrombus. Over the
following 6 weeks she had up to 15 episodes of diarrhoea
daily, with ongoing bleeding with each bowel motion. Stool
culture was sterile. IV hydrocortisone was initiated, the
diarrhoea improved slightly but the bleeding pr (per rectum)
continued. Coagulation screen and platelets were normal.
The patient suffered a significant hematemeisis and died 5
months following presentation. Postmortem examination
revealed amyloidosis affecting the heart, lungs, liver, spleen
and kidneys. Examination of the small and large bowel
revealed mucosal ulceration and amyloid deposition of thes 5 (2006) 59 – 61ed by Elsevier B.V. All rights reserved.
Fig. 1. Vascular amyloid deposition in small bowel wall (Congo red stain).
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demonstrated nodular sclerosing Hodgkins disease.2. Case 2
A 27-year-old male was diagnosed with CF at age 5. No
genotyping was available. He was admitted to hospital
complaining of facial and lower limb oedema, nausea,
lethargy, increased sputum production and dyspnoea. Serum
chemistry showed urea 4.1 mmol/l, creatinine 89 umol/l,
albumin 14 g/l, and 24 h urine collection for protein was 10.8
g/24 h. Renal ultrasound demonstrated hypoechoic regions, a
renal biopsy confirmed amyloidosis.
The renal function was monitored and erythropoietin was
instituted 18 months after the diagnosis of amyloidosis. Six
months following this, he was admitted with a respiratory
exacerbation, his FEV1 was 0.9l. Serum chemistry showed:
potassium 4.2 mmol/l, urea 19.3 mmol/l, creatinine 542
umol/l, and albumin 11 g/l. Haemodialysis was instituted.
He continued to deteriorate and died 3 months after
presentation from renal failure.3. Case 3
A 36-year-old male CF (homozygous DF508), presented
with ankle oedema and his FEV1 was 1.2l. Serum chemistry
showed urea 6.1 mmol/l, creatinine 89 umol/l and urine
collection 18 g of protein in 24 h. Renal biopsy confirmed
amyloidosis. He was treated with diuretics and ACE
inhibitors. Six months later he was admitted with an
infectious exacerbation and bowel obstruction, he required
dialysis however deteriorated over 6 weeks and died.4. Discussion
The association between CF and amyloidosis has been
previously reported. We describe three additional casesone of whom presented with multiple thrombi and colonic
ulceration causing bleeding and diarrhoea. A hemorrhagic
diathesis due to amyloidosis has never been described in
CF.
The incidence of amyloid in CF is unknown. In a
retrospective review of autopsies from 33 patients with CF
who were at least 15 years old when they died, 33% had
amyloidosis, principally in the spleen, liver and kidneys.
However, no differences were noted between the groups
with respect to time of diagnosis with CF, number, severity
or type of infections or longevity [1]. On literature review,
the average age of diagnosis of CF in patients who
subsequently developed amyloidosis was 7.5 years (range
birth to 22). It has been suggested that inadequate treatment
of pulmonary disease in childhood may predispose to the
development of amyloid [2]. This underlines the benefit of
neonatal screening as this may reduce the risk of
amyloidosis. Interestingly amyloid has been reported more
frequently in male patients (15 of 22 patients, 68%), which
may reflect their increased life expectancy. Thyroid
amyloid infiltration has been described, however there
was no evidence to indicate thyroid disease in theses cases
[3–5].
A number of hypotheses have been proposed to explain
the appearance of amyloidosis in CF patients. Inadequate
treatment of CF in childhood may predispose to amyloid-
osis by causing increased pulmonary and systemic
inflammation. It has been suggested that amyloid is related
to increased levels of SAA in CF patients colonised with
pseudomonas aeruginosa, the concentration of SAA is
influenced by antibiotic exposure decreasing with treat-
ment and increasing afterwards [6]. The majority of
reported cases (15/19) have died within 1 year of the
diagnosis of amyloid indicating that it is a poor prognostic
factor.
A bleeding diathesis is a recognised complication of
amyloidosis and may affect any organ system. This may be
related to coagulation deficits or due to amyloid infiltration
of vessels leading to fragility of blood vessels and decreased
ability for healing [7]. In a series of 100 patients with
amyloidosis, 41 patients experienced bleeding episodes:
petechiae and eccchymosis (23), gastrointestinal bleeding
(18), bleeding following a diagnostic procedure (8),
haematuria (3), haemoptysis (2) and miscellaneous (2) [8].
Amyloid angiopathy should be included in the differential
diagnosis of spontaneous haemorrhage in patients with
advanced CF. In addition, our patient suffered numerous
intravascular thrombi. Thrombosis of the inferior vena cava
has been reported in primary and secondary amyloidosis and
it is possible that loss of vascular integrity and endothelial
dysfunction due to amyloidosis may predispose to thrombi
[9,10].
Herein, we report a case of amyloid presenting as a
thrombotic and hemorrhagic diathesis in CF. As the life
expectancy of patients with CF increases it is likely that
amyloidosis will be seen with increasing frequency.
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